SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001415889-12-001241
Filing Date
2012-08-14
Accepted
2012-08-14 13:36:19
Documents
9
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q bazi10qjune302012.htm 10-Q 447113
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 14336
3 EXHIBIT 32.1 ex32-1.htm EX-32 5991
  Complete submission text file 0001415889-12-001241.txt   2284636

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT bazi-20120630.xml EX-101.INS 181117
5 XBRL TAXONOMY SCHEMA DOCUMENT bazi-20120630.xsd EX-101.SCH 36493
6 XBRL TAXONOMY PRESENTATION LINKBASE bazi-20120630_pre.xml EX-101.PRE 129703
7 XBRL TAXONOMY LABEL LINKBASE bazi-20120630_lab.xml EX-101.LAB 208276
8 XBRL TAXONOMY DEFINITION LINKBASE bazi-20120630_def.xml EX-101.DEF 37308
9 XBRL TAXONOMY CALCULATION LINKBASE bazi-20120630_cal.xml EX-101.CAL 27065
Mailing Address 1730 BLAKE STREET, SUITE 305 DENVER CO 80202
Business Address 1730 BLAKE STREET, SUITE 305 DENVER CO 80202 303 316-8577
BAZI INTERNATIONAL, INC. (Filer) CIK: 0001134765 (see all company filings)

IRS No.: 841575085 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32420 | Film No.: 121031419
SIC: 2833 Medicinal Chemicals & Botanical Products